WATS3D is changing the way Barrett's esophagus and dysplasia are diagnosed and surveilled.

A New Standard of Care - When and why WATS3D should be used

Watch an excerpt from an EndoscopyNow webinar with Michael S Smith, MD, MBA and Sri Komanduri, MD

WATS3D's enhanced wide-area tissue sampling instrument helps to reduce sampling error in Barrett's esophagus.

“At the current time, endoscopists rely solely on taking small random forceps biopsies at 1-2 cm intervals, leaving more than 96% of the endoscopically suspect area completely untested.” — Prashanth R Vennalaganti, MD, University of Kansas, School of Medicine, Kansas City, KS

WATS3D's increased adjunctive yield of HGD or EAC by 428%.

WATS3D detected an additional 23 cases of HGD/EAC that were missed using Seattle protocol alone.

LEARN MORE ABOUT OUR CLINICAL EVIDENCE
  • EAC=esophageal adenocarcinoma;
  • GIE=Gastrointestinal Endoscopy;
  • HGD=high-grade dysplasia.